Proliferative effect of Apidra^® (insulin glulisine), a rapid-acting insulin analogue on mammary epithelial cellsSHUKLA, Ashish; ENZMANN, Harald; MAYER, Doris et al.Archives of physiology and biochemistry. 2009, Vol 115, Num 3, pp 119-126, issn 1381-3455, 8 p.Article

Insulin glulisine provides improved glycemic control in patients with type 2 diabetesDAILEY, George; ROSENSTOCK, Julio; MOSES, Robert G et al.Diabetes care. 2004, Vol 27, Num 10, pp 2363-2368, issn 0149-5992, 6 p.Article

Insulin glulisine : An evaluation of its pharmacodynamic properties and clinical applicationHELMS, Kristen L; KELLEY, Kristi W.The Annals of pharmacotherapy. 2009, Vol 43, Num 4, pp 658-668, issn 1060-0280, 11 p.Article

Les nouvelles insulines : intérêts et inconvénients = New insulins : interests and convenientsSOLA, A; LARGER, E; M'BEMBA, J et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 6, pp 454-460, issn 1624-0693, 7 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of Insulin GlulisineBECKER, Reinhard H. A; FRICK, Annke D.Clinical pharmacokinetics. 2008, Vol 47, Num 1, pp 7-20, issn 0312-5963, 14 p.Article

Insulin glulisine. CommentaryROBINSON, Dean M; WELLINGTON, Keri; DAILEY, George et al.Drugs (Basel). 2006, Vol 66, Num 6, pp 861-872, issn 0012-6667, 12 p.Article

Insulin Glulisine Has a Faster Onset of Action Compared with Insulin Aspart in Healthy VolunteersARNOLDS, S; RAVE, K; HÖVELMANN, U et al.Experimental and clinical endocrinology & diabetes. 2010, Vol 118, Num 9, pp 662-664, issn 0947-7349, 3 p.Article

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp techniqueBECKER, R. H. A; FRICK, A. D; BURGER, F et al.Experimental and clinical endocrinology & diabetes. 2005, Vol 113, Num 5, pp 292-297, issn 0947-7349, 6 p.Article

Dose-response relationship of insulin glulisine in subjects with type 1 diabetesBECKER, Reinhard H. A; FRICK, Annke D; NOSEK, Leszek et al.Diabetes care. 2007, Vol 30, Num 10, pp 2506-2507, issn 0149-5992, 2 p.Article

Effects of the rapid-acting insulin analog glulisine on Cultured human Skeletal muscle cells: Comparisons with Insulin and insulin-like growth factor ICIARALDI, Theodore P; PHILLIPS, Susan A; CARTER, Leslie et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 10, pp 5551-5558, issn 0021-972X, 8 p.Article

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjectsBECKER, R. H. A; FRICK, A. D; BURGER, F et al.Experimental and clinical endocrinology & diabetes. 2005, Vol 113, Num 8, pp 435-443, issn 0947-7349, 9 p.Article

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetesDANNE, Thomas; BECKER, Reinhard H. A; HEISE, Tim et al.Diabetes care. 2005, Vol 28, Num 9, pp 2100-2105, issn 0149-5992, 6 p.Article

Advantage ol premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetesRAVE, Klaus; KLEIN, Oliver; FRICK, Annke D et al.Diabetes care. 2006, Vol 29, Num 8, pp 1812-1817, issn 0149-5992, 6 p.Article

Insuline glulisine - : Une nouvelle insuline à action rapide = Insulin glulisine (Apidra) : a new rapid-acting insulinThe Medical letter on drugs and therapeutics (Edition française). 2006, Vol 28, Num 11, pp 47-48, issn 0253-8512, 2 p.Article

Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial DesignLEVIN, Philip A; QUANWU ZHANG; MERSEY, James H et al.Clinical therapeutics. 2011, Vol 33, Num 7, pp 841-850, issn 0149-2918, 10 p.Article

Insuline glulisine (APIDRA°) : Pas plus d'intérêt chez les enfants que chez les adultes = Insulin glulisine (APIDRA°) : No more interest for children than for adultsLa Revue Prescrire. 2009, Vol 29, Num 304, pp 91-91, issn 0247-7750, 1 p.Article

Insulin Glulisine = A Review of its Use in the Management of Diabetes MellitusGARNOCK-JONES, Karly P; PLOSKER, Greg L.Drugs (Basel). 2009, Vol 69, Num 8, pp 1035-1057, issn 0012-6667, 23 p.Article

Adjust to Target in Type 2 Diabetes : Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisineBERGENSTAL, Richard M; JOHNSON, Mary; POWERS, Margaret A et al.Diabetes care. 2008, Vol 31, Num 7, pp 1305-1310, issn 0149-5992, 6 p.Article

Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetesDZYGALO, Katarzyna; SZYPOWSKA, Agnieszka.European journal of endocrinology. 2014, Vol 170, Num 4, pp 539-545, issn 0804-4643, 7 p.Article

Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial StateHOHBERG, Clothilde; FORST, Thomas; LARBIG, Martin et al.Diabetes care. 2008, Vol 31, Num 5, pp 1021-1025, issn 0149-5992, 5 p.Article

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptorsHENNIGE, A. M; STRACK, V; METZINGER, E et al.Diabetologia (Berlin). 2005, Vol 48, Num 9, pp 1891-1897, issn 0012-186X, 7 p.Article

Insuline glulisine ^(Apidra°): Me too : 3^E analogue d'action ultrarapide de l'insuline, sans plus = Glulisine insulin : critical studyLa Revue Prescrire. 2006, Vol 26, Num 272, pp 328-328, issn 0247-7750, 1 p.Article

New Insulin Analogues and Routes of Delivery : Pharmacodynamic and Clinical ConsiderationsROACH, Paris.Clinical pharmacokinetics. 2008, Vol 47, Num 9, pp 595-610, issn 0312-5963, 16 p.Article

Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study: A Randomized Noninferiority TrialHARRIS, Stewart B; YALE, Jean-François; BERARD, Lori et al.Diabetes care. 2014, Vol 37, Num 3, pp 604-610, issn 0149-5992, 7 p.Article

A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal InsufficiencyBALDWIN, David; ZANDER, Jennifer; MUNOZ, Christina et al.Diabetes care. 2012, Vol 35, Num 10, pp 1970-1974, issn 0149-5992, 5 p.Article